NCT Number: NCT02049333
Cataract Surgery vs Cataract Surgery With ECPL for Treatment of Plateau Iris Configuration or Syndrome
The purpose of this study is to assess and compare the mechanical angle opening in patients with angle closure due to a plateau iris configuration (elevated iris) using phacoemulsification combined with endoscopic cycloplasty versus treatment with phacoemulsification alone.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Osler EyeCare, Brampton, Ontario, Canada
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Patient has to be ≥ 18 years of age of either gender
- Nuclear sclerotic cataract graded by LOCS III to be < 5
- Diagnosis of Plateau Iris Configuration or Syndrome
- No contraindication for cataract or ECPL operation
- Written informed consent on IRB approved Informed Consent Form
Exclusion criteria
- Hard cataracts, LOCS III 5 and 6
- Ciliary body cysts
- Clinically significant sequelae from trauma in which angle anatomy/physiology may have been compromised (e.g., chemical burns, significant angle recession, blunt trauma, etc.)
- Congenital anomaly of the irido-trabecular angle
- Previous intraocular surgery
- Previous laser gonioplasty to either eye
- Placement of the intraocular lens in any place other than the capsular bag
- Pupilloplasty
- Rubeosis
- Peripheral anterior synechiae (PAS) nasal angle and/or >180 degrees of PAS
- Neovascular glaucoma; or glaucoma associated with vascular ischemic disorders
- Active corneal inflammation or edema (e.g., keratitis, keratoconjunctivitis, keratouveitis)
- Corneal opacities or disorders that would inhibit visualization of the nasal angle
- Chronic ocular inflammatory disease or presence of active ocular inflammation with risk for synechial/proliferative changes
- Inability to attend regular follow-up assessment or to give informed written consent.
Treatment and study plan
Endoscopic Cycloplasty (ECPL)
ProcedurePrimary outcomes
-
Anterior Chamber Angle Depth (nasal angle)
Time frame: Twelve months
Anterior chamber angle depth (nasal angle) measured using the Shaffer grading system and via anterior segment imaging
Secondary outcomes
-
Number of glaucoma medications
Time frame: Twelve months post-op
The number of glaucoma medications will be recorded and compared to pre-operative number of glaucoma medications.
-
Intraocular pressure (IOP)
Time frame: Twelve months post-op
IOP will be recorded and compared to pre-operative IOP.
Other outcomes
-
Intra- and post-operative complications
Time frame: Up to one year after surgery
Analyzing any unexpected complications from the surgery such as prolonged hypotony, intraocular pressure spike, prolonged corneal inflammation etc. This will be done during the clinic visit and analyzed under slit lamp examination.
Sponsors and collaborators
Lead sponsor
Credit Valley EyeCare
Industry
Registry information
Official study title
Phacoemulsification Versus Phacoemulsification With Endoscopic Cycloplasty (ECPL) for Treatment of Plateau Iris Configuration or Syndrome: A Prospective Randomized Clinical and Surgical Study
Important dates
- Study start
- 2010
- Primary completion
- 2013
- Study completion
- 2013
- First posted
- Jan 30, 2014
- Registry last updated
- Jan 30, 2014
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
The Effect of ROCK Inhibitors on Corneas of Patients With Glaucoma and Pseudophakic Bullous Keratopathy (PBK)
NCT06960629
Corneal Diseases, Corneal Edema
Zagreb, Croatia
View Trial DetailsVW-50 Feasibility Study
NCT07730424
Eye Diseases, Glaucoma
Fitzroy, Victoria, Australia
View Trial DetailsPhase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension
NCT07168902
Eye Diseases, Glaucoma
Glendale, California, United States
View Trial DetailsAI for the Detection of Retinal Disease and Glaucoma in Patients With Diabetes Mellitus in Primary Care
NCT04132401
Age-Related Macular Degeneration, Cardiovascular Diseases
Manresa, Barcelona, Spain
View Trial Details